Scarica l'app Stockscreener
0.00
100.00%
-0.0111
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.0111
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$N/A
Reddito:
$547.00K
Utile/perdita netta:
$-34.02M
Rapporto P/E:
0.00
EPS:
-47.04
Flusso di cassa netto:
$-27.11M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
+221.67%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$1.15
Trevena Inc Stock (TRVN) Company Profile
Compare TRVN vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TRVN
Trevena Inc
|
0.00 | 0 | 547.00K | -34.02M | -27.11M | -47.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Trevena Inc Stock (TRVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-03-15 | Iniziato | Oppenheimer | Perform |
| 2020-09-14 | Iniziato | Guggenheim | Buy |
| 2020-08-28 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-05-31 | Ripresa | H.C. Wainwright | Buy |
| 2018-11-05 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2018-10-12 | Downgrade | Needham | Buy → Hold |
| 2018-10-10 | Downgrade | Jefferies | Buy → Hold |
| 2017-11-08 | Reiterato | Needham | Buy |
| 2017-10-16 | Downgrade | Barclays | Overweight → Equal Weight |
| 2017-10-12 | Reiterato | H.C. Wainwright | Buy |
| 2017-05-08 | Reiterato | Needham | Buy |
| 2017-02-23 | Reiterato | H.C. Wainwright | Buy |
| 2017-02-22 | Reiterato | FBR & Co. | Outperform |
| 2017-02-02 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-01-09 | Iniziato | H.C. Wainwright | Buy |
| 2017-01-05 | Iniziato | Oppenheimer | Outperform |
| 2016-05-17 | Reiterato | FBR Capital | Outperform |
| 2016-05-17 | Reiterato | Needham | Buy |
| 2016-03-29 | Iniziato | FBR Capital | Outperform |
| 2015-09-01 | Reiterato | Wedbush | Outperform |
| 2015-08-03 | Iniziato | Brean Capital | Buy |
Mostra tutto
Trevena Inc Borsa (TRVN) Ultime notizie
Novakand Pharma applies for Nasdaq's approval of continued listing - marketscreener.com
S&P 500, Nasdaq turn negative; S&P down 0.4%, Nasdaq falls 0.9% - marketscreener.com
Trevena (NASDAQ:TRVN) Share Price Passes Above Fifty Day Moving Average – Should You Sell? - Defense World
Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - The Manila Times
Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum: - GlobeNewswire
What technical patterns form on Trevena Inc. (6T4) stock chartsJuly 2025 Market Mood & Fast Entry and Exit Trade Plans - bollywoodhelpline.com
Critical Contrast: Ampio Pharmaceuticals (NYSE:AMPE) vs. Trevena (NASDAQ:TRVN) - Defense World
Trevena Restructures China Royalty Rights to Exit Debt - TipRanks
Trevena Signs Assignment and Release Agreement With R-Bridge Investment Four and Jiangsu Nhwa Pharmaceutical - TradingView — Track All Markets
Trevena (NASDAQ:TRVN) Shares Cross Below Fifty Day Moving Average – Here’s What Happened - Defense World
How Trevena Inc. (6T4) stock valuation compares with sectorQuarterly Portfolio Review & Risk Managed Investment Entry Signals - ulpravda.ru
Analyst Upgrade: How Trevena Inc. (6T4) stock benefits from digital adoptionJuly 2025 Action & Long Hold Capital Preservation Tips - ulpravda.ru
Published on: 2026-01-09 03:04:06 - ulpravda.ru
Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors - MEXC
Published on: 2026-01-09 00:14:30 - ulpravda.ru
RMTICurrent Report Filing (8-k) - ADVFN
Trevena Inc. (TRVN) Stock Price | Live Quotes & Charts | EXPM - StocksToTrade
Critical Review: Vincerx Pharma (NASDAQ:VINC) & Trevena (NASDAQ:TRVN) - Defense World
Cash per share of Trevena, Inc. – BER:6T4 - TradingView — Track All Markets
Why Trevena Inc 6T4 stock stays undervaluedRisk Management & Low Drawdown Trading Techniques - moha.gov.vn
EBIT per share of Trevena, Inc. – MUN:6T4 - TradingView — Track All Markets
Will Trevena Inc. (6T4) stock outperform small cap peersWeekly Trade Recap & Community Verified Trade Signals - Newser
Is Trevena Inc. (6T4) stock undervalued by metricsJuly 2025 PreEarnings & Long-Term Investment Growth Plans - Newser
Can Trevena Inc. (6T4) stock reach $200 price targetJuly 2025 Analyst Calls & Weekly Chart Analysis and Trade Guides - Newser
How Trevena Inc. (6T4) stock reacts to new regulations2025 Geopolitical Influence & Weekly High Momentum Picks - Newser
Why Trevena Inc. (6T4) stock is favored by hedge fundsWeekly Profit Report & Fast Gain Stock Tips - Newser
Will Trevena Inc. (6T4) stock deliver stable dividends2025 Pullback Review & Advanced Technical Analysis Signals - Newser
Will Trevena Inc. (6T4) stock extend growth storyMarket Performance Report & Precise Buy Zone Tips - Newser
Smood Sweets Redefines Better-for-You Candy with Launch of "Candy Dates" – Joined by Entrepreneur and Actor Oliver Trevena - Nosh.com
Cash per share of Trevena, Inc. – MUN:6T4 - TradingView
P 500 performance this yearJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - newser.com
What downside risks could hit Trevena Inc. (6T4) stockWeekly Trade Review & Trade Opportunity Analysis Reports - newser.com
How Trevena Inc. (6T4) stock stacks up against competitorsWeekly Trend Recap & Verified Stock Trade Ideas - newser.com
Is Trevena Inc. (6T4) stock a top pick for value investors2025 Support & Resistance & Verified Swing Trading Watchlists - newser.com
Why Trevena Inc. (6T4) stock could outperform next yearPortfolio Value Summary & Weekly Watchlist of Top Performers - newser.com
Is Trevena Inc. (6T4) stock suitable for passive index funds2025 Breakouts & Breakdowns & Technical Confirmation Alerts - newser.com
Trevena Inc Azioni (TRVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.12%
0.87%
Capitalizzazione:
|
Volume (24 ore):